Cannabis May Treat Migraines, Finds New Study

Findings from a new study published in the journal European Journal of Pharmacology shows that cannabis may serve as an effective treatment for migraine headaches.

“Current anti-migraine treatments have limited efficacy and many side effects”, begins the abstract of the study. “Although anecdotal evidence suggests that marijuana is useful for migraine, this hypothesis has not been tested in a controlled experiment.” Thus, the present study “tested whether administration of ∆9-tetrahydrocannabinol (THC) produces anti-migraine effects in the female rat.”

The results from the study “suggest that: 1) THC reduces migraine-like pain when administered at the right dose (0.32mg/kg) and time; 2) THC’s anti-migraine effect is mediated by CB1 receptors. These findings “support anecdotal evidence for the use of cannabinoids as a treatment for migraine in humans and implicate the CB1 receptor as a therapeutic target for migraine.”

Read moreCannabis May Treat Migraines, Finds New Study

Study: Cannabinoids Reduce Frequency of Migraines

By Paul Armentano, NORML

The prolonged daily administration of cannabinoids is associated with a reduction in migraine headache frequency, according to clinical trial data presented at the 3rd Congress of the European Academy of Neurology.

Italian researchers compared the efficacy of oral cannabinoid treatments versus amitriptyline – an anti-depressant commonly prescribed for migraines – in 79 chronic migraine patients over a period of three months. Subjects treated daily with a 200mg dose of a combination of THC and CBD achieved a 40 percent reduction in migraine frequency – a result that was similar to the efficacy of amitriptyline therapy.

Subjects also reported that cannabinoid therapy significantly reduced acute migraine pain, but only when taken at doses above 100mg. Oral cannabinoid treatment was less effective among patients suffering from cluster headaches.

Read moreStudy: Cannabinoids Reduce Frequency of Migraines

Watermelon Marijuana Strain Overview

Watermelon is a heavy indica that’s the perfect treat to cap off the night.

Watermelon

Watermelon is an indica-dominant marijuana strain (typically 80/20) that is known for having thick, dense nuggets, similar to Granddaddy Purple. The flavor is that of berries and grape, with a similar smell that lingers in the room well after a smoke session.

Watermelon is a vaunted strain by growers, mostly because of its high yield compared to other strains; but, of course, also because of its potency and flavor.

Some of its top effects include:

  • Relaxation
  • Happiness
  • Sleepiness
  • Increased Appetite

Some of the top medical ailments it helps with are:

  • Insomnia
  • Depression
  • Stress
  • Anxiety
  • Post traumatic stress disorder (PTSD)
  • Pain and also
  • Headaches/Migraines

Reviews:

At the time of publication Watermelon has 78 reviews on Leafly with an average score of 4.4 out of 5.

Where to find it

If you live in a state where cannabis is legal, you may want to check out Leafly’s strain finder. This feature can use your exact location to find the closet cannabis store or dispensary to you that is currently carrying the Watermelon marijuana strain; you can also look for a variety of other strains.

Click here for this strain finder.

Study: 100% Of Those with Migraines, Fibromyalgia and IBS Find Reduction Of Pain with Marijuana

By The National Pain Report

migrainesOne-hundred percent (100%) of people with migraine headache, fibromyalgia or irritable bowel syndrome who use medical marijuana for a minimum of 30 days report a reduction in pain and discomfort, a 6-month study conducted by Care By Design found.

People included in the survey suffer from a range of different conditions, and some suffer from multiple conditions, including:

Read moreStudy: 100% Of Those with Migraines, Fibromyalgia and IBS Find Reduction Of Pain with Marijuana

Illinois State Board Recommends Migraines, PTSD and Other Ailments As Medical Cannabis Conditions

The illinoismedicalIllinois Medical Cannabis Advisory Board on Monday voted to recommend a variety of medical ailments as conditions that qualify an individual to become a legal medical cannabis patient.

The Board voted 8 to 2 to recommend to the Illinois Department of Health that migraines be added as qualifying conditions for medical cannabis use. The panel voted unanimously to recommend irritable bowel syndrome, post traumatic stress disorder, periphery polyneuropathy and diabetic neuropathy, and voted 7 to 4 to recommend osteoarthritis.

Read moreIllinois State Board Recommends Migraines, PTSD and Other Ailments As Medical Cannabis Conditions

Activating Cannabinoid Receptors May Treat Migraines, According to New Study

A new study published by the Journal of Headache and Pain has found that activation of the body’s cannabinoid receptorsmigraine – something done naturally by cannabis – may treat migraines.

The study, titled Activation of CB2 receptors as a potential therapeutic target for migraine: evaluation in an animal model, used male rats to study the effects of a cannabinoid receptor agonist (an activator) on the treatment of severe migraines.

Read moreActivating Cannabinoid Receptors May Treat Migraines, According to New Study

Cannabinoid Deficiency May Cause Migraines, Fibromyalgia and Irritable Bowel Syndrome

A meta-study being published in the upcoming issue of the journal NeuroendocrinologyMedicalMarijuana2-JCR.jpg Letters, and published online ahead of print by the U.S. National Institute of Health, has found that cannabinoid deficiency may play a role in migraines, fribromyalgia, irritable bowel syndrome and other medical conditions, indicating that cannabinoid intake may provide a treatment option for these ailments.

For the study; “Available literature was reviewed, including searches via the National Library of medicine database and other sources.”

Read moreCannabinoid Deficiency May Cause Migraines, Fibromyalgia and Irritable Bowel Syndrome